Sabby Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-3,451
Closed -$36.1M 365
2016
Q3
$36.1M Buy
3,451
+2,756
+397% +$298K 1.35% 13
2016
Q2
$6.86M Buy
695
+382
+122% +$39.5K 0.36% 46
2016
Q1
$3.75M Hold
313
0.19% 58
2015
Q4
$3.75M Buy
+313
New +$36.2K 0.21% 77
2015
Q1
Sell
-280
Closed -$3.13K 356
2014
Q4
$3.13K Sell
280
-2,040
-88% -$215K 0.1% 95
2014
Q3
$22K Sell
2,320
-948
-29% -$85.6K 0.84% 22
2014
Q2
$28.1M Buy
+3,268
New +$249K 1.2% 16
2014
Q1
Sell
-420
Closed -$3.55M 318
2013
Q4
$3.55M Sell
420
-1,194
-74% -$94.5K 0.23% 58
2013
Q3
$12.4M Sell
1,614
-7,930
-83% -$556K 0.81% 33
2013
Q2
$55.8M Buy
+9,544
New +$574K 3.72% 4

Other funds holding CELG

Sabby Management's CELG Position: Q4 2016 in Review

Sabby Management sold out of Celgene Corp (CELG) in Q4 2016, closing a stake of 37,728 shares — an estimated $3.94M sold.

Sabby Management first reported a position in CELG in Q1 2014 and held it in 3 quarters. The position peaked at $3.94M in Q3 2016. 1,375 funds tracked by Wall St. Rank hold CELG as of Q4 2016.

  • Sabby Management reported no remaining Celgene Corp position as of Q4 2016 after selling out during the quarter.
  • Sabby Management sold 37,728 Celgene Corp shares in Q4 2016, an estimated $3.94M.
  • Sabby Management first reported a position in Celgene Corp in Q1 2014 and held it in 3 quarters.
  • Sabby Management's Celgene Corp position peaked at $3.94M in Q3 2016.
  • 1,375 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2016.

Based on Sabby Management's 13F filing for Q4 2016, filed 14 Feb 2017.